MAP
TMDX icon

Moody Aldrich Partners’s Transmedics TMDX Stock Holding History

Moody Aldrich Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,733
Closed -$4.04M – 220
2024
Q3 		$4.04M Sell
25,733
-448
-2% -$69K 0.73% 62
2024
Q2 		$3.94M Sell
26,181
-8,349
-24% -$1M 0.77% 61
2024
Q1 		$2.55M Sell
34,530
-11,782
-25% -$971K 0.43% 85
2023
Q4 		$3.66M Buy
46,312
+24,290
+110% +$1.47M 0.66% 68
2023
Q3 		$1.21M Sell
22,022
-5,839
-21% -$420K 0.23% 109
2023
Q2 		$2.34M Sell
27,861
-141
-0.5% -$10.8K 0.45% 86
2023
Q1 		$2.12M Buy
+28,002
New +$1.94M 0.43% 87
2022
Q3 		– Sell
-106,798
Closed -$3.36M – 173
2022
Q2 		$3.36M Sell
106,798
-81,523
-43% -$2.17M 0.66% 68
2022
Q1 		$5.07M Buy
188,321
+22,243
+13% +$399K 0.71% 55
2021
Q4 		$3.18M Buy
166,078
+32,209
+24% +$807K 0.44% 79
2021
Q3 		$4.43M Buy
+133,869
New +$4.09M 0.56% 75

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Moody Aldrich Partners's TMDX Position: Q4 2024 in Review

Moody Aldrich Partners sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 25,733 shares — an estimated $4.04M sold.

Moody Aldrich Partners first reported a position in TMDX in Q3 2021 and held it in 11 quarters. The position peaked at $5.07M in Q1 2022. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Moody Aldrich Partners reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Moody Aldrich Partners sold 25,733 Transmedics shares in Q4 2024, an estimated $4.04M.
  • Moody Aldrich Partners first reported a position in Transmedics in Q3 2021 and held it in 11 quarters.
  • Moody Aldrich Partners's Transmedics position peaked at $5.07M in Q1 2022.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Moody Aldrich Partners's 13F filing for Q4 2024, filed 23 Jan 2025.